16.86
price up icon0.06%   0.010
after-market アフターアワーズ: 16.86
loading
前日終値:
$16.85
開ける:
$16.87
24時間の取引高:
351.56K
Relative Volume:
0.63
時価総額:
$873.82M
収益:
$109.78M
当期純損益:
$114.54M
株価収益率:
7.6476
EPS:
2.2046
ネットキャッシュフロー:
$268.74M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-0.82%
6か月 パフォーマンス:
-10.98%
1年 パフォーマンス:
+51.08%
1日の値動き範囲:
Value
$16.85
$16.88
1週間の範囲:
Value
$16.84
$16.92
52週間の値動き範囲:
Value
$10.82
$21.03

Theravance Biopharma Inc Stock (TBPH) Company Profile

Name
名前
Theravance Biopharma Inc
Name
セクター
Healthcare (1079)
Name
電話
650-808-6000
Name
住所
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
Name
職員
90
Name
Twitter
Name
次回の収益日
2026-08-11
Name
最新のSEC提出書
Name
TBPH's Discussions on Twitter

Compare TBPH vs VRTX, REGN, ARGX, RVMD, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
TBPH icon
TBPH
Theravance Biopharma Inc
16.86 873.82M 109.78M 114.54M 268.74M 2.2046
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
477.10 121.57B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
762.63 69.95B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
853.82 55.61B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
187.53 39.98B 742.00K -1.37B -1.07B -7.0731
ONC icon
ONC
Beone Medicines Ltd Adr
316.01 33.81B 5.76B 514.49M 1.10B 4.4813

Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-05 ダウングレード Oppenheimer Outperform → Perform
2026-03-04 ダウングレード B. Riley Securities Buy → Neutral
2025-12-03 開始されました Oppenheimer Outperform
2025-09-12 開始されました B. Riley Securities Buy
2024-08-06 ダウングレード Leerink Partners Outperform → Market Perform
2024-04-12 開始されました BTIG Research Buy
2024-01-08 ダウングレード Evercore ISI Outperform → In-line
2022-05-23 開始されました SVB Leerink Outperform
2021-11-05 アップグレード JP Morgan Underweight → Neutral
2021-09-15 ダウングレード JP Morgan Overweight → Underweight
2021-08-25 ダウングレード Morgan Stanley Overweight → Underweight
2021-08-24 ダウングレード Cowen Outperform → Market Perform
2020-10-14 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-07 開始されました JP Morgan Overweight
2020-06-15 開始されました Morgan Stanley Equal-Weight
2020-05-13 開始されました Cowen Outperform
2020-01-08 繰り返されました H.C. Wainwright Buy
2019-11-06 アップグレード Robert W. Baird Underperform → Neutral
2019-10-29 開始されました H.C. Wainwright Buy
2018-03-29 再開されました Piper Jaffray Overweight
2017-08-17 開始されました Evercore ISI Outperform
2017-06-16 開始されました Cantor Fitzgerald Overweight
2017-05-11 繰り返されました Needham Buy
2016-12-21 開始されました Needham Buy
2016-11-03 開始されました Piper Jaffray Overweight
2016-10-12 ダウングレード Robert W. Baird Neutral → Underperform
2016-08-03 ダウングレード BofA/Merrill Neutral → Underperform
2016-06-20 開始されました Guggenheim Buy
2016-06-20 繰り返されました Leerink Partners Outperform
2016-05-12 開始されました Leerink Partners Outperform
2016-05-05 ダウングレード BofA/Merrill Buy → Neutral
2015-02-03 アップグレード Robert W. Baird Underperform → Neutral
すべてを表示

Theravance Biopharma Inc (TBPH) 最新ニュース

pulisher
Jul 27, 2026

ETFs Investing in Theravance Biopharma Inc Stocks - TradingView

Jul 27, 2026
pulisher
Jul 27, 2026

Theravance Biopharma Inc (TBPH) Cash Flow - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

TBPH|Theravance Biopharma Inc|Price:16.865|Chg%:+0.005 - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

Theravance Biopharma Inc (TBPH) Balance Sheet - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Theravance Biopharma Inc (TBPH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Theravance Biopharma Inc (TBPH) Institutional Confidence - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Theravance Biopharma Inc (TBPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Theravance Biopharma Inc Revenue Breakdown – FWB:0TB - TradingView

Jul 26, 2026
pulisher
Jul 25, 2026

Theravance Biopharma Inc Revenue Breakdown – LS:A1137V - TradingView

Jul 25, 2026
pulisher
Jul 24, 2026

Theravance Biopharma Inc (TBPH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026
pulisher
Jul 23, 2026

Theravance Biopharma Inc (TBPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 23, 2026
pulisher
Jul 21, 2026

Liquidity Mapping Around (TBPH) Price Events - Stock Traders Daily

Jul 21, 2026
pulisher
Jul 16, 2026

Zymeworks Won’t Host Q2 Call Amid Proposed Theravance Deal - Stock Titan

Jul 16, 2026
pulisher
Jul 16, 2026

Zymeworks to report Q2 2026 results on August 6, no earnings call due to Theravance Biopharma acquisition plans - Pluang

Jul 16, 2026
pulisher
Jul 09, 2026

Theravance Biopharma (TBPH) Hovers Near Support Amidst Quiet Trading SessionProtective Put - dars.gov.et

Jul 09, 2026
pulisher
Jul 09, 2026

Are TBPH, IRDM, LCII, PATK Obtaining Fair Deals for their Shareholders? - Finansavisen

Jul 09, 2026
pulisher
Jul 08, 2026

Theravance stock down 3% after Zymeworks announces buyout - MSN

Jul 08, 2026
pulisher
Jul 08, 2026

TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its Shareholders - AOL.com

Jul 08, 2026
pulisher
Jul 07, 2026

Theravance Biopharma Price Target Raised to $17.00/Share From $15.00 by HC Wainwright & Co. - Moomoo

Jul 07, 2026
pulisher
Jul 07, 2026

H.C. Wainwright Downgrades Theravance Biopharma(TBPH.US) to Hold Rating, Raises Target Price to $17 - Moomoo

Jul 07, 2026
pulisher
Jul 05, 2026

Zymeworks' $929 Million Pivot: How a COPD Acquisition Redefines Its Future - Kavout | AI

Jul 05, 2026
pulisher
Jul 05, 2026

TBPHTheravance Biopharma Inc Options - Finviz

Jul 05, 2026
pulisher
Jul 04, 2026

If You Invested $1,000 in Theravance Bioph (TBPH) - Stock Titan

Jul 04, 2026
pulisher
Jul 03, 2026

Arthur Cox advises on pharmaceutical sector acquisition - ICLG

Jul 03, 2026
pulisher
Jul 03, 2026

Theravance Biopharma Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SurpriseEarnings Season Review - dars.gov.et

Jul 03, 2026
pulisher
Jul 02, 2026

TBPH News | THERAVANCE BIOPHARMA INC (NASDAQ:TBPH) - ChartMill

Jul 02, 2026
pulisher
Jul 02, 2026

Zymeworks to pay $17/share for Theravance Biopharma in $929M deal - MSN

Jul 02, 2026
pulisher
Jul 02, 2026

Theravance Biopharma Insider Sold Shares Worth $5,791,555, According to a Recent SEC Filing - marketscreener.com

Jul 02, 2026
pulisher
Jul 01, 2026

Theravance Biopharma(TBPH.US) 10% Shareholder Sells US$5.79 Million in Common Stock - Moomoo

Jul 01, 2026
pulisher
Jul 01, 2026

Funds tied to Eli Samaha trim Theravance Biopharma (TBPH) stake in open-market sales - Stock Titan

Jul 01, 2026
pulisher
Jul 01, 2026

Here’s Why Zymeworks Inc. Paid $929M For Theravance Biopharma (NASDAQ:ZYME) - Seeking Alpha

Jul 01, 2026
pulisher
Jul 01, 2026

TBPH SEC FilingsTheravance Bioph 10-K, 10-Q, 8-K Forms - Stock Titan

Jul 01, 2026
pulisher
Jul 01, 2026

Arthur Cox advises Theravance Biopharma on its $929 million merger with Zymeworks - Arthur Cox LLP

Jul 01, 2026
pulisher
Jun 30, 2026

Zymeworks to Acquire Theravance Biopharma in $929 Million Transaction - Global Legal Chronicle

Jun 30, 2026
pulisher
Jun 30, 2026

Canadian Zymeworks acquires American Theravance Biopharma for $929 million - AKM.RU

Jun 30, 2026
pulisher
Jun 30, 2026

After a three-decade legacy, Theravance agreed to a complex sale for less than $1 billion - The Business Journals

Jun 30, 2026
pulisher
Jun 30, 2026

Theravance Stock Down 3% After Zymeworks Announces Buyout - Yahoo Finance

Jun 30, 2026
pulisher
Jun 30, 2026

Press Release: Zymeworks to Acquire Theravance Biopharma, Inc. - Moomoo

Jun 30, 2026
pulisher
Jun 30, 2026

Zymeworks agrees to buy Theravance Biopharma for $929m - Pharmaceutical Technology

Jun 30, 2026
pulisher
Jun 30, 2026

TBPH Downgraded by BTIG -- Rating Changed to Neutral - GuruFocus

Jun 30, 2026
pulisher
Jun 29, 2026

Vancouver biotech Zymeworks buying Theravance for US$929M - Castanet

Jun 29, 2026
pulisher
Jun 29, 2026

Zymeworks to Acquire Theravance Biopharma, Inc. - Indovizka.com

Jun 29, 2026
pulisher
Jun 29, 2026

Zymeworks Inc to Acquire Theravance Biopharma Inc Transcript - GuruFocus

Jun 29, 2026
pulisher
Jun 29, 2026

Zymeworks offers US$929-million for COPD drug maker Theravance - The Globe and Mail

Jun 29, 2026
pulisher
Jun 29, 2026

Zymeworks to buy Theravance Biopharma in $929M deal – a look at what this deal means for TBPH shareholders - MSN

Jun 29, 2026
pulisher
Jun 29, 2026

Zymeworks Buys Theravance To Execute On New Business Strategy - insights.citeline.com

Jun 29, 2026
pulisher
Jun 29, 2026

Theravance Biopharma (TBPH) Downgraded to Hold Following $929M A - GuruFocus

Jun 29, 2026
pulisher
Jun 29, 2026

Theravance downgraded at Jones on Zymeworks acquisition - MSN

Jun 29, 2026
pulisher
Jun 29, 2026

Are IRDM, TBPH, SYNA, TECH Obtaining Fair Deals for their Shareh - GuruFocus

Jun 29, 2026
pulisher
Jun 29, 2026

Are IRDM, TBPH, SYNA, TECH Obtaining Fair Deals for their Shareholders? - Finviz

Jun 29, 2026
pulisher
Jun 29, 2026

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Theravance Biopharma, Inc. (NASDAQ: TBPH) - PR Newswire

Jun 29, 2026

Theravance Biopharma Inc (TBPH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Theravance Biopharma Inc (TBPH) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Samaha Eli
10% Owner
Jul 01 '26
Sale
17.00
37,799
642,628
9,174,453
Samaha Eli
10% Owner
Jun 30 '26
Sale
17.13
25,027
428,788
9,212,252
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Jun 15 '26
Sale
16.39
13,314
218,167
232,457
$90.58
price down icon 2.44%
$119.52
price down icon 2.82%
$33.91
price down icon 1.77%
$58.43
price down icon 1.00%
$205.52
price up icon 0.02%
ONC ONC
$316.01
price down icon 1.88%
大文字化:     |  ボリューム (24 時間):